Cycloserine

Product NDC
43598-235
11-digit product format
435980235
Labeler code
43598
Product ID
43598-235_426b2c99-759d-647a-420f-fc11b205486b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cycloserine
Dosage form
CAPSULE
Route
ORAL
Labeler
Dr. Reddy�s Laboratories, Inc.
Application
ANDA060593
Marketing category
ANDA
Marketing start
2023-03-15
Substance
CYCLOSERINE
Active strength
250 mg/1
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A060593-001SEROMYCINCYCLOSERINE250MGCAPSULE / ORALRS, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A060593-001SEROMYCIN250MGCAPSULE / ORALRS, Approved before 1982f41ea6bd6efb…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Cycloserine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CYCLOSERINE250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
95IK5KI84ZInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
197551Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8e7e2665-7a3d-3f54-9f92-5fe845f02ef9Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
43598-235-312024-07-30C16284748780-11030e365-5608-111a-e063-dadaa90a10e2Cycloserine Capsules USP, 250 mg
43598-235-312024-01-30C16284748780-11030e365-5608-111a-e063-dadaa90a10e2Cycloserine Capsules USP, 250 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43598-235-10Cycloserine10 in 1 BLISTER PACKCAPSULE103
43598-235-31Cycloserine3 in 1 CARTONCAPSULE33

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
43598-235-10EA - Each43598-235b0cb24bc-7674-432d-9b94-7a1eb768f60d12023-04-07
43598-235-31EA - Each43598-2355eaede93-bcdc-4248-905c-f0148a8f91db12023-04-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43598-235CYCLOSERINE CAPSULE [DR. REDDY’S LABORATORIES, INC.]3Current NDC, 2 package rows20240731_8e7e2665-7a3d-3f54-9f92-5fe845f02ef9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CycloserineCYCLOSERINEDr. Reddys Laboratories, Inc.8e7e2665-7a3d-3f54-9f92-5fe845f02ef92024-07-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 060593
application number: ANDA060593
ndc (product): 43598-235

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
197551cycloSERINE 250 MG Oral CapsulePSN8e7e2665-7a3d-3f54-9f92-5fe845f02ef93
197551cycloserine 250 MG Oral CapsuleSCD8e7e2665-7a3d-3f54-9f92-5fe845f02ef93

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
43598-235-104359802351010 in 1 BLISTER PACKHistorical
43598-235-31435980235313 BLISTER PACK in 1 CARTON (43598-235-31) / 10 CAPSULE in 1 BLISTER PACK (43598-235-10) 3 blister pack2023-03-15NoNoCurrent